Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis

Area of Science:

• Metabolic health
• Digital health
• Personalized nutrition

Background:

• Type 2 diabetes management remains a significant global health challenge.
• Traditional approaches often lack personalization, leading to suboptimal outcomes.
• The integration of technology offers new avenues for improving glycemic control and metabolic parameters.

Purpose of the Study:

• To evaluate the impact of the Twin Precision Nutrition (TPN) Program on key diabetes metrics.
• To assess changes in hemoglobin A1c (HbA1c), insulin resistance, and medication use.
• To determine the efficacy of a digital twin-enabled precision nutrition intervention over 90 days.

Main Methods:

• Retrospective analysis of 64 patients with type 2 diabetes in the TPN Program.
• Utilized a machine learning algorithm analyzing daily continuous glucose monitor (CGM) and food intake data.
• Physicians monitored patients and titrated medications based on daily CGM data.

Main Results:

• Mean HbA1c decreased by 1.9% (from 8.8% to 6.9%).
• Mean weight decreased by 6.1% (from 79.0 kg to 74.2 kg).
• Homeostatic model assessment of insulin resistance (HOMA-IR) decreased by 56.9% (from 7.4 to 3.2).
• Significant reductions in anti-diabetic medication use were observed across multiple drug classes.

Conclusions:

• The TPN Program demonstrates significant benefits for type 2 diabetes patients.
• Precision nutrition guidance driven by CGM, food data, and machine learning is effective.
• The intervention led to substantial improvements in glycemic control, weight, insulin resistance, and medication reduction.